| Grant number: | 16/18527-3 |
| Support Opportunities: | Scholarships in Brazil - Post-Doctoral |
| Start date: | January 01, 2017 |
| End date: | November 30, 2020 |
| Field of knowledge: | Biological Sciences - Immunology |
| Agreement: | Coordination of Improvement of Higher Education Personnel (CAPES) |
| Principal Investigator: | Isabel Kinney Ferreira de Miranda Santos |
| Grantee: | Gabriane Nascimento Porcino |
| Host Institution: | Faculdade de Medicina de Ribeirão Preto (FMRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil |
| Associated scholarship(s): | 19/15738-1 - I.Study of Total Serum N-glycan signatures in infections with Leishmania infantum in a Brazilian population, BE.EP.PD |
Abstract Visceral leishmaniasis (VL) may be fatal if not treated and, although hypergammaglobulinemia is a hallmark of VL, the contribution of antibodies in progression of disease remains unknown. Effector and regulatory functions of antibodies rely on their interactions with type I and II Fc receptors and these interactions are tuned by the patterns of antibody Fc N-glycosylation. We recently showed that, in comparison to healthy individuals, the overall IgG Fc N-glycan profiles are profoundly altered in VL patients and, together with serum regulators of immune responses (cytokines and C-reactive protein), we demonstrated the ability of IgG Fc glyco features to predict disease severity in VL patients. Importantly, we showed that Fc N-glycosylation profiles change after treatment of VL. We will begin to uncover the potential role of IgG Fc glyco features in the pathogenesis of VL and the mechanisms that participate in those alterations with the following studies: (i) we will evaluate global gene expression profiles of B cells isolated from patients stratified into categories of disease severity, and associate them with titers and profiles of Fc Nglycosylation of IgG specific for leishmania antigens; (ii) based on the knowledge acquired by our study on VL patients, we will test the viability and efficacy of new strategies of therapy in an experimental hamster model of progressive VL. We will evaluate the effects of treatment of hamsters chronically infected with L. infantum with intravenous immunoglobulin preparations enriched with sialic acid, and in vivo enzymatic deglycosylation of IgG Fc. Thus, we expect to obtain insights into the mechanisms by which IgG Fc glyco features influence progression and severity of VL and to innovate the treatment of the disease. | |
| News published in Agência FAPESP Newsletter about the scholarship: | |
| More itemsLess items | |
| TITULO | |
| Articles published in other media outlets ( ): | |
| More itemsLess items | |
| VEICULO: TITULO (DATA) | |
| VEICULO: TITULO (DATA) | |